The Middle East & Africa human leukocyte antigen (HLA) testing market is expected to grow from US$ 35.78 million in 2022 to US$ 52.59 million by 2028; it is estimated to grow at a CAGR of 6.6% from 2022 to 2028.
Despite the development of novel technological approaches such as optimized chemotherapy regimens, targeted therapies, and radiotherapy, patients suffering from many diseases still present poor survival outcomes. Technological advancements in histocompatibility have systematically addressed the issues related to the specificity of lymphocyte cross-matching. Treating a wide range of malignant and nonmalignant diseases requires hematopoietic stem cell transplantation (HSCT) as the last therapeutic resort. The HLA testing approach can help determine if the class I and II antibodies lead to a cross-match. The information obtained from the application of such sensitive and specific technologies can be used to predict cross-match results for highly sensitized patients.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa human leukocyte antigen (HLA) testing market growth at a notable CAGR during the forecast period.
Despite the development of novel technological approaches such as optimized chemotherapy regimens, targeted therapies, and radiotherapy, patients suffering from many diseases still present poor survival outcomes. Technological advancements in histocompatibility have systematically addressed the issues related to the specificity of lymphocyte cross-matching. Treating a wide range of malignant and nonmalignant diseases requires hematopoietic stem cell transplantation (HSCT) as the last therapeutic resort. The HLA testing approach can help determine if the class I and II antibodies lead to a cross-match. The information obtained from the application of such sensitive and specific technologies can be used to predict cross-match results for highly sensitized patients.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa human leukocyte antigen (HLA) testing market growth at a notable CAGR during the forecast period.
Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Segmentation
The Middle East & Africa human leukocyte antigen (HLA) testing market is segmented into product & services, technology, end user, and country.- Based on product & services, the market is segmented into reagents & consumables, instruments, and software & services. In terms of technology, the Middle East & Africa human leukocyte antigen (HLA) testing market is divided into molecular assay technologies and non-molecular assay technologies. The molecular assay technologies segment is sub segmented into PCR-based molecular assays, sequencing-based molecular assays, and others.
- Based on end user, the market is divided into independent reference laboratories, hospital and transplant centers, and others.
- Based on country, the Middle East & Africa human leukocyte antigen (HLA) testing market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa.
Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market - Companies Mentioned
THERMO FISHER SCIENTIFIC INC.; CareDx; QIAGEN; Illumina; Bio-Rad Laboratories, Inc.; F. HOFFMANN-LA ROCHE LTD.; and Takara Bio Inc. are among the major companies operating in the Middle East & Africa human leukocyte antigen (HLA) testing market.Table of Contents
1. Introduction
3. Research Methodology
4. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Market Landscape
5. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Key Market Dynamics
6. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market -Analysis
7. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 - by Product and Services
8. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by Technology
9. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by End User
10. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by country
11. Middle East and Africa Human Leukocyte Antigen (HLA) Testing Market - Industry Landscape
12. Company Profiles
13. Appendix
Companies Mentioned
- THERMO FISHER SCIENTIFIC INC.
- CareDx
- QIAGEN
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- F. HOFFMANN-LA ROCHE LTD.
- Takara Bio Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | September 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 35.78 Million |
| Forecasted Market Value ( USD | $ 52.59 Million |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Africa, Middle East |
| No. of Companies Mentioned | 7 |
